<PAGE>   1
 
================================================================================
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                             ---------------------
 
                                  FORM 10-Q/A
 
<TABLE>
<S>              <S>
   (MARK ONE)
      [X]        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                 THE SECURITIES EXCHANGE ACT OF 1934

                 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 1997
                                              OR
      [  ]       TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                 THE SECURITIES EXCHANGE ACT OF 1934

                 FOR THE TRANSITION PERIOD FROM ____________ TO ____________
</TABLE>
 
                        Commission file number 000-19480
                              MEDAPHIS CORPORATION
             (Exact name of Registrant as specified in its charter)
 
<TABLE>
<S>                                            <C>
                  DELAWARE                                      58-1651222
       (State or other jurisdiction of                       (I.R.S. Employer
       incorporation or organization)                       Identification No.)

     2700 CUMBERLAND PARKWAY, SUITE 300                            30339
              ATLANTA, GEORGIA                                  (Zip code)
  (Address of principal executive offices)
</TABLE>
 
                                 (770) 444-5300
              (Registrant's telephone number, including area code)
 
                                 NOT APPLICABLE
   (Former name, former address and former fiscal year, if changed since last
                                    report)
 
     Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.  Yes [X]  No [ ]
 
     Indicate the number of shares of stock outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.
 
<TABLE>
<CAPTION>
               CLASS                    OUTSTANDING AT APRIL 30, 1997
               -----                    -----------------------------
<C>                                  <C>
           Common Stock
          $0.01 PAR VALUE                     72,429,480 SHARES
      Non-voting Common Stock
          $0.01 PAR VALUE                         0 SHARES
</TABLE>
 
================================================================================
<PAGE>   2
 
                              MEDAPHIS CORPORATION
 
                                  FORM 10-Q/A
                                 MARCH 31, 1997
 
<TABLE>
<CAPTION>
                                                              PAGE
                                                              ----
<S>                                                           <C>
Part I: Financial Information
  Consolidated Statements of Operations for the three months
     ended March 31, 1997 and 1996..........................    3
  Consolidated Balance Sheets as of March 31, 1997 and
     December 31, 1996......................................    4
  Consolidated Statements of Cash Flows for the three months
     ended March 31, 1997 and 1996..........................    5
  Notes to Consolidated Financial Statements................    6
  Management's Discussion and Analysis of Financial
     Condition and Results of Operations....................   18
Part II: Other Information
  Legal Proceedings.........................................   24
  Other Information.........................................   26
  Exhibits and Reports on Form 8-K..........................   27
  Index to Exhibits.........................................   30
</TABLE>
 
                             ---------------------
 
     THIS FORM 10-Q/A AND OTHER STATEMENTS ISSUED OR MADE FROM TIME TO TIME BY
MEDAPHIS CORPORATION OR ITS REPRESENTATIVES CONTAIN STATEMENTS WHICH MAY
CONSTITUTE "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE SECURITIES ACT
OF 1933 AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED BY THE PRIVATE
SECURITIES LITIGATION REFORM ACT OF 1995. 15 U.S.C.A. SECTIONS 77Z-2 AND 78U-5
(SUPP. 1996). THOSE STATEMENTS INCLUDE STATEMENTS REGARDING THE INTENT, BELIEF
OR CURRENT EXPECTATIONS OF MEDAPHIS CORPORATION AND MEMBERS OF ITS MANAGEMENT
TEAM AS WELL AS THE ASSUMPTIONS ON WHICH SUCH STATEMENTS ARE BASED. PROSPECTIVE
INVESTORS ARE CAUTIONED THAT ANY SUCH FORWARD-LOOKING STATEMENTS ARE NOT
GUARANTEES OF FUTURE PERFORMANCE AND INVOLVE RISKS AND UNCERTAINTIES, AND THAT
ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CONTEMPLATED BY SUCH
FORWARD-LOOKING STATEMENTS. IMPORTANT FACTORS CURRENTLY KNOWN TO MANAGEMENT THAT
COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN FORWARD-LOOKING
STATEMENTS ARE SET FORTH IN THE SAFE HARBOR COMPLIANCE STATEMENT FOR
FORWARD-LOOKING STATEMENTS INCLUDED AS EXHIBIT 99.1 TO THIS FORM 10-Q/A, AND ARE
HEREBY INCORPORATED HEREIN BY REFERENCE. THE COMPANY UNDERTAKES NO OBLIGATION TO
UPDATE OR REVISE FORWARD-LOOKING STATEMENTS TO REFLECT CHANGED ASSUMPTIONS, THE
OCCURRENCE OF UNANTICIPATED EVENTS OR CHANGES TO FUTURE OPERATING RESULTS OVER
TIME.
 
                                        2
<PAGE>   3
 
PART I:  FINANCIAL INFORMATION
 
ITEM 1.  FINANCIAL STATEMENTS
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
               CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
                     (IN THOUSANDS, EXCEPT PER SHARE DATA)
 
<TABLE>
<CAPTION>
                                                                    THREE MONTHS ENDED
                                                                         MARCH 31,
                                                              -------------------------------
                                                                   1997             1996
                                                              --------------   --------------
                                                              (AS RESTATED,    (AS RESTATED,
                                                               SEE NOTE 8)      SEE NOTE 8)
<S>                                                           <C>              <C>
Revenue.....................................................     $147,546         $162,249
Salaries and wages..........................................       93,578           91,730
Other operating expenses....................................       40,242           39,335
Depreciation................................................        6,985            5,940
Amortization................................................        6,114            6,533
Interest expense, net.......................................        6,115            2,105
Restructuring and other charges.............................           --              306
                                                                 --------         --------
          Total expenses....................................      153,034          145,949
Income (loss) before income taxes...........................       (5,488)          16,300
Income tax (benefit) expense................................       (2,424)           7,230
                                                                 --------         --------
          Net income (loss).................................       (3,064)           9,070
Pro forma income tax adjustments............................           --              354
                                                                 --------         --------
          Pro forma net income (loss).......................     $ (3,064)        $  9,424
                                                                 ========         ========
Pro forma net income (loss) per common share................     $  (0.04)        $   0.12
                                                                 ========         ========
Weighted average shares outstanding.........................       72,235           75,704
                                                                 ========         ========
</TABLE>
 
                See notes to consolidated financial statements.
 
                                        3
<PAGE>   4
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
                          CONSOLIDATED BALANCE SHEETS
                     (IN THOUSANDS, EXCEPT PAR VALUE DATA)
 
<TABLE>
<CAPTION>
                                                                MARCH 31,       DECEMBER 31,
                                                                   1997             1996
                                                              --------------   --------------
                                                               (UNAUDITED)
                                                              (AS RESTATED,    (AS RESTATED,
                                                               SEE NOTE 8)      SEE NOTE 8)
<S>                                                           <C>              <C>
                                           ASSETS
Current Assets:
  Cash......................................................     $ 10,174        $   7,631
  Restricted cash...........................................       19,952           19,568
  Accounts receivable, billed...............................      101,728           99,823
  Accounts receivable, unbilled.............................       75,017           79,911
  Deferred tax asset........................................       36,177           36,177
  Other.....................................................       13,809           12,129
                                                                 --------        ---------
          Total current assets..............................      256,857          255,239
Property and equipment......................................       92,798           97,850
Deferred tax asset..........................................       45,473           43,044
Intangible assets...........................................      531,852          539,151
Other.......................................................        3,698            1,570
                                                                 --------        ---------
                                                                 $930,678        $ 936,854
                                                                 ========        =========
                            LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
  Accounts payable..........................................     $ 14,698        $  11,765
  Accrued compensation......................................       34,086           30,332
  Accrued expenses..........................................       90,710          100,675
  Current portion of long-term debt.........................      106,955           55,975
                                                                 --------        ---------
          Total current liabilities.........................      246,449          198,747
Long-term debt..............................................      162,720          215,752
Other obligations...........................................       12,331           13,830
                                                                 --------        ---------
          Total liabilities.................................      421,500          428,329
                                                                 --------        ---------
Stockholders' Equity:
  Common stock, voting, $0.01 par value, 200,000 authorized
     in 1997 and 1996; issued and outstanding 72,417 in 1997
     and 71,705 in 1996.....................................          724              717
  Common stock, non voting, $0.01 par value, 600 authorized
     in 1997 and 1996; none issued..........................           --               --
  Paid-in capital...........................................      670,336          666,673
  Accumulated deficit.......................................     (161,882)        (158,696)
                                                                 --------        ---------
                                                                  509,178          508,694
  Less treasury stock, at cost -- 16 shares in 1996.........           --             (169)
                                                                 --------        ---------
          Total stockholders' equity........................      509,178          508,525
                                                                 --------        ---------
                                                                 $930,678        $ 936,854
                                                                 ========        =========
</TABLE>
 
                See notes to consolidated financial statements.
 
                                        4
<PAGE>   5
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
               CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
                                 (IN THOUSANDS)
 
<TABLE>
<CAPTION>
                                                                    THREE MONTHS ENDED
                                                                        MARCH 31,
                                                              ------------------------------
                                                                  1997             1996
                                                              -------------    -------------
                                                              (AS RESTATED,    (AS RESTATED,
                                                               SEE NOTE 8)      SEE NOTE 8)
<S>                                                           <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net income (loss).........................................    $ (3,064)        $  9,070
  Adjustments to reconcile net income (loss) to net cash
     provided by (used for) operating activities:
     Depreciation and amortization..........................      13,099           12,473
     (Gain) loss on sale of property and equipment..........        (102)             210
     Deferred income taxes..................................      (2,429)           7,230
     Changes in assets and liabilities, excluding effects of
      acquisitions:
       Increase in accounts receivable, billed..............      (1,905)         (16,195)
       Decrease (increase) in accounts receivable,
        unbilled............................................       4,893           (7,115)
       Increase (decrease) in accounts payable..............       2,933           (8,634)
       Increase in accrued compensation.....................       3,754            9,016
       Decrease in accrued expenses.........................     (10,260)          (9,629)
       Other, net...........................................      (1,042)            (598)
                                                                --------         --------
          Net cash provided by (used for) operating
            activities......................................       5,877           (4,172)
                                                                --------         --------
CASH FLOWS FROM INVESTING ACTIVITIES:
  Acquisitions, net of cash acquired........................        (769)          (5,722)
  Purchases of property and equipment.......................      (3,400)         (19,467)
  Proceeds from sale of property and equipment..............       3,644               13
  Software development costs................................      (1,398)         (13,419)
                                                                --------         --------
          Net cash used for investing activities............      (1,923)         (38,595)
                                                                --------         --------
CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from issuance of common stock....................       3,618            7,660
  Proceeds from borrowings..................................      10,000           43,566
  Principal payments of long-term debt......................     (12,020)         (13,782)
  Other.....................................................      (3,009)           3,819
                                                                --------         --------
          Net cash (used for) provided by financing
            activities......................................      (1,411)          41,263
                                                                --------         --------
CASH:
  Net change................................................       2,543           (1,504)
  Balance at beginning of period............................       7,631           18,979
                                                                --------         --------
  Balance at end of period..................................    $ 10,174         $ 17,475
                                                                ========         ========
SUPPLEMENTAL DISCLOSURES:
  Cash paid for:
     Interest...............................................    $  4,615         $  3,551
     Income taxes...........................................         612              629
  Non-cash investing and financing activities:
     Liabilities assumed in acquisitions....................          --            2,027
     Additions to capital lease obligations.................          --            9,190
     Common stock issued upon conversion of subordinated
      debentures............................................          --           63,375
</TABLE>
 
                See notes to consolidated financial statements.
 
                                        5
<PAGE>   6
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
 
NOTE 1 -- BASIS OF PRESENTATION
 
     The accompanying unaudited condensed consolidated financial statements of
Medaphis Corporation ("Medaphis" or the "Company") are presented in accordance
with the requirements of Form 10-Q and Rule 10-01 of Regulation S-X. For further
information, the reader of this Form 10-Q/A may wish to refer to the audited
consolidated financial statements of the Company for the fiscal years ended
December 31, 1996 and 1997 included in the Company's Annual Report on Form 10-K
filed February 2, 1998 ("10-K").
 
     The unaudited condensed financial information has been prepared in
accordance with the Company's customary accounting policies and practices. In
the opinion of management, all adjustments, consisting of normal recurring
adjustments considered necessary for a fair presentation of results for the
interim period, have been included.
 
     The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues
and expenses. Actual results could differ from those estimates.
 
     As in the past, the Company's consolidated financial statements have been
prepared on a going concern basis which contemplates the realization of assets
and the settlement of liabilities and commitments in the normal course of
business. On March 31, 1997, the Company's independent auditors noted in a
modifying fourth paragraph to their unqualified independent report on the
Company's financial statements included in the 10-K that, because the Company's
plans to divest of certain assets to generate funds to meet scheduled 1997
amortization requirements did not then include binding contracts to dispose of
these assets, and because no other contractual arrangements were in place to
refinance or raise additional funds to otherwise satisfy such required debt
reduction, substantial doubt was raised about the Company's ability to continue
as a going concern. As discussed in Note 7, the Company's cash flow from
operations will not be sufficient to satisfy required reductions in the
Company's outstanding borrowings; however, as discussed in the next paragraph,
the Company has adopted plans to divest certain assets which management believes
will generate the necessary cash flows to satisfy these required debt
reductions. The Company's consolidated financial statements do not include any
adjustments relating to the recoverability and classification of liabilities
that may be necessary should the Company, contrary to plans and expectations, be
unable to continue as a going concern.
 
     As previously discussed in the Company's 10-K, the Company and its lenders
have always contemplated that the contractual amortization of loan commitments
under the Second Amended and Restated Loan Facility (the "Second Amended
Facility") would be accomplished through asset divestitures since operating cash
flow was never intended to be utilized for this purpose and would be
insufficient to meet these obligations. Also as previously announced and
pursuant to the Company's 1997 business plan, the Company is pursuing the sale
of Healthcare Recoveries, Inc. ("HRI") and the assessment of alternatives for
its client/server integration businesses (the "BSG Group"). On April 22, 1997,
the Company announced that its two-pronged divestiture strategy for HRI, either
through a private sale or an initial public offering (in which it is being
advised by Bear, Stearns & Co. Inc.) continued to be on track. The Company also
reported that one or more private sale preliminary indications of interest for
the purchase of HRI have been received that are in excess of the funds required
to satisfy 1997 amortization obligations under the Second Amended Facility. The
Company has also filed the HRI registration statement with the SEC which is
completing its review process. The preliminary prospectus (subject to
completion) was distributed by the Company during the week of April 28, 1997.
The Company remains confident that it will be able to meet its amortization
obligations under the Second Amended Facility through the continued execution of
the Company's 1997 business plan and related asset divestiture program.
 
                                        6
<PAGE>   7
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
NOTE 2 -- LEGAL MATTERS
 
     The United States Attorney's Office for the Central District of California
is conducting an investigation (the "Federal Investigation") of Medaphis'
billing and collection practices in its offices located in Calabasas and
Cypress, California (the "Designated Offices"). Medaphis first became aware of
the Federal Investigation when it received search warrants and grand jury
subpoenas on June 13, 1995. Although the precise scope of the Federal
Investigation is not known to the Company at this time, Medaphis believes that
the U.S. Attorney's Office is investigating allegations of billing fraud and
that the inquiry is focused upon Medaphis' billing and collection practices in
the Designated Offices. Numerous federal and state civil and criminal laws
govern medical billing and collection activities. In general, these laws provide
for various fines, penalties, multiple damages, assessments and sanctions for
violations, including possible exclusion from Medicare, Medicaid and certain
other federal and state healthcare programs. Although the Designated Offices
represent less than 2% of Medaphis' annual revenue, there can be no assurance
that the Federal Investigation will be resolved promptly, that additional
subpoenas or search warrants will not be received by Medaphis or that the
Federal Investigation will not have a material adverse effect upon the Company.
The Company recorded charges of $12 million in the third quarter of 1995 and $2
million in the fourth quarter of 1996, solely for the administrative fees, costs
and expenses it anticipates incurring in connection with the Federal
Investigation and the putative class action lawsuits described below which were
filed following the Company's announcement of the Federal Investigation. The
charges are intended to cover only the anticipated expenses of the Federal
Investigation and the related lawsuits and do not include any provision for
fines, penalties, damages, assessments, judgments or sanctions that may arise
out of such matters.
 
     Following the announcement of the Federal Investigation, Medaphis, various
of its current and former officers and directors and the lead underwriters
associated with Medaphis' public offering of common stock in April 1995 were
named as defendants in putative shareholder class action lawsuits filed in the
United States District Court for the Northern District of Georgia. In general,
these lawsuits allege violations of the federal securities laws in connection
with Medaphis' public statements and filings under the federal securities acts,
including the registration statement filed in connection with Medaphis' public
offering of common stock in April 1995. On October 13, 1995, the named
plaintiffs in these lawsuits filed a consolidated class action complaint (the
"Consolidated Complaint"). On January 3, 1996, the court denied defendants'
motion to dismiss the Consolidated Complaint. On April 11, 1996, certain of the
named plaintiffs to the Consolidated Complaint voluntarily dismissed with
prejudice all of their claims. As a result of these dismissals, the Consolidated
Complaint no longer contains any claims based on the Securities Act of 1933, as
amended, and the Company's underwriters and outside directors are no longer
named as defendants. On June 26, 1996, the court denied the plaintiffs' motion
to certify a plaintiffs' class. The plaintiffs and the defendants have reached
an agreement in principle to settle this action on a class-wide basis for $4.75
million, subject to court approval and other customary conditions (the "1995
Class Action Settlement"). The 1995 Class Action Settlement would also include
the related putative class action lawsuit currently pending in the Superior
Court of Cobb County, Georgia, described more fully below. The Company expects
to receive approximately $3.7 million from insurance to fund a portion of the
1995 Class Action Settlement and accrued approximately $1.2 million in the
quarter ending December 31, 1996 to fund the anticipated balance of the 1995
Class Action Settlement and to pay certain fees incident thereto.
 
     On November 5, 1996, Medaphis, Randolph G. Brown, Michael R. Cote and James
S. Douglass were named as defendants in a putative shareholder class action
lawsuit filed in Superior Court of Cobb County, State of Georgia. This lawsuit
alleges violations of Georgia securities laws based on the same public
statements and filings generally described above. The lawsuit is brought on
behalf of a putative class of purchasers of Medaphis common stock during the
period from March 29, 1995 through June 15, 1995. The plaintiffs seek
compensatory damages and costs. As noted above, it is currently contemplated
that this action will be settled as part of the 1995 Class Action Settlement.
 
                                        7
<PAGE>   8
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
     The Company and its clients from time to time have received, and the
Company anticipates that they will receive in the future, official inquiries
(including subpoenas, search warrants, as well as informal requests) concerning
particular billing and collection practices related to certain subsidiaries of
the Company and its many clients. In March 1997, the Company was informed by the
Civil Division of the Department of Justice that it is investigating allegations
concerning the Company's Gottlieb's Financial Services, Inc. ("GFS") subsidiary.
The Company has received a request from the Department of Justice for records,
and may receive additional requests. The Company intends to cooperate in
producing records. There can be no assurance that this matter will be resolved
promptly or that the investigation will not have a material adverse effect upon
Medaphis.
 
     Following the Company's August 14, 1996 announcement regarding earnings
expectations and certain charges, Medaphis and certain of its current and former
officers, one of whom was also a director, were named as defendants in nineteen
putative shareholder class action lawsuits filed in the United States District
Court for the Northern District of Georgia. On November 22, 1996, the plaintiffs
in these lawsuits filed a Consolidated Amended Class Action Complaint (the "1996
Consolidated Complaint"). In general, the 1996 Consolidated Complaint alleges
violations of the federal securities laws in connection with Medaphis' filings
under the federal securities acts and public disclosures. The 1996 Consolidated
Complaint is brought on behalf of a class of all persons who purchased or
otherwise acquired Medaphis common stock between January 6, 1996 and October 21,
1996. The 1996 Consolidated Complaint also asserts claims on behalf of a
sub-class of all persons who acquired Medaphis common stock pursuant to the
merger between Medaphis and Health Data Sciences Corporation ("HDS"). On
December 30, 1996, the defendants filed a motion to dismiss most of the 1996
Consolidated Complaint. On February 3, 1997, the plaintiffs filed a Consolidated
Second Amended Complaint. On February 14, 1997, the defendants moved to dismiss
the Consolidated Second Amended Complaint in its entirety.
 
     On November 1, 1996, Thomas W. Brown, Administrator, Thomas W. Brown Profit
Sharing Plan filed a shareholder derivative lawsuit in the United States
District Court for the Northern District of Georgia alleging that certain of
Medaphis' current and former directors breached their fiduciary duties, were
grossly negligent, and breached various contractual obligations to Medaphis by
allegedly failing to implement and maintain an adequate system of internal
accounting controls, allowing Medaphis to commit securities law violations and
damaging Medaphis' reputation. The plaintiff seeks compensatory damages and
costs. On January 28, 1997, Medaphis and certain individual defendants filed a
motion to dismiss the complaint. On February 11, 1997, the plaintiff filed an
amended complaint adding as defendants additional current and former directors
and officers of Medaphis. On April 23, 1997, Medaphis and certain of the
defendants filed a motion to dismiss the amended complaint.
 
     On November 7, 1996, Health Systems International, Inc. filed suit in the
Superior Court for the State of California, County of Los Angeles against
Medaphis, Randolph G. Brown and "Does 1-50," who are alleged to be unnamed
Medaphis directors, officers and employees. Generally, this lawsuit alleges that
the defendants violated federal and California securities laws and common law
by, among other things more fully described in the complaint, making material
misstatements and omissions in public and private disclosures in connection with
the acquisition of HDS. Plaintiff seeks rescissory, compensatory and punitive
damages, rescission, injunctive relief and costs. On January 10, 1997, the
defendants filed a demurrer to the complaint. The demurrer was denied on
February 5, 1997. On March 18, 1997, the court denied the plaintiff's motion for
a preliminary injunction. As a result of the Company's restatement of its fiscal
1995 financial statements, the Company may not be able to sustain a defense to
strict liability on certain claims under the 1933 Act, but the Company believes
that it has substantial defenses to the alleged damages relating to the 1933 Act
claims.
 
     A putative class action complaint was filed by Ernest Hecht and Stephen D.
Strandberg against Steven G. Papermaster, Robert E. Pickering, Jr., David S.
Lundeen, Norman Smith, Raymond J. Noorda, Gregory A. Grosh, Medaphis and
Randolph G. Brown on November 12, 1996 in the Superior Court, Law Division,
 
                                        8
<PAGE>   9
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
Essex County, State of New Jersey. The alleged class consists of persons and
entities whose options to purchase BSG Corporation ("BSG") common stock were
converted to Medaphis stock options in connection with Medaphis' acquisition of
BSG. The plaintiffs allege failure to perform diligence, breaches of fiduciary
duties of candor, loyalty and fair dealing and negligence against the BSG
defendants (Papermaster, Pickering, Lundeen, Smith, Noorda and Grosh) and fraud
and deceit against the Medaphis defendants (Medaphis and Brown). On April 18,
1997, the Medaphis defendants and BSG defendants filed motions to dismiss the
complaint.
 
     On February 28, 1997, Steven G. Papermaster, Raymond J. Noorda and two
entities they control made a demand for indemnification under an indemnification
agreement executed by Medaphis in connection with its acquisition of BSG in May
1996. On the date of the demand, Mr. Papermaster was an executive officer and a
director of Medaphis. Mr. Papermaster resigned such positions on March 21, 1997,
although he remains an executive officer of BSG. The indemnification demand
claims damages of $35 million (the maximum damages payable by Medaphis under the
indemnification agreement) for the alleged breach by the Company of its
representations and warranties made in the merger agreement between Medaphis and
BSG.
 
     On April 21, 1997, James F. Thacker, Alyson T. Stinson, Carol T. Shumaker,
Lori T. Caudill, William J. Dezonia, the James F. Thacker Retained Annuity
Trust, and the Paulanne H. Thacker Retained Annuity Trust filed a complaint
against the Company and Randolph G. Brown in the United States District Court
for the Southern District of New York arising out of Medaphis' acquisition of
Medical Management Sciences, Inc. ("MMS") in December of 1995. The complaint is
brought on behalf of all former shareholders of MMS who exchanged their MMS
holdings for unregistered shares of Medaphis common stock. In general, the
complaint alleges both common law fraud and violations of the federal securities
laws in connection with the merger. In addition, the complaint alleges breaches
of contract relating to the merger agreement and a registration rights
agreement, as well as tortious interference with economic advantage. The
plaintiffs seek rescission of the merger agreement and the return of all MMS
shares, as well as damages in excess of $100 million. Additionally, plaintiffs
seek to void various noncompete covenants and contract provisions between
Medaphis and plaintiffs.
 
     The Company also has received other written demands from various
stockholders, including stockholders of recently acquired companies.
 
     On January 8, 1997, the Securities and Exchange Commission (the
"Commission") notified the Company that it is conducting a non-public
investigation into, among other things, certain trading and other issues related
to Medaphis' August 14, 1996 and October 22, 1996 announcements of the Company's
loss for the quarter ending September 30, 1996 and its restated consolidated
financial statements for the three months and year ended December 31, 1995 and
its restated unaudited balance sheets as of March 31, 1996 and June 30, 1996.
The Company intends to cooperate fully with the Commission in its investigation.
 
     Although the Company believes that it has meritorious defenses to the
claims of liability or for damages in the actions against, and written demands
placed upon the Company, there can be no assurance that additional lawsuits will
not be filed against the Company, that the lawsuits, the written demands and the
pending governmental investigations will not have a disruptive effect upon the
operations of the business, that the written demands, the defense of the
lawsuits and the pending investigations will not consume the time and attention
of the senior management of the Company or that the resolution of the lawsuits,
the written demands and the pending governmental investigations will not have a
material adverse effect upon the Company.
 
                                        9
<PAGE>   10
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
NOTE 3 -- ACQUISITIONS AND OTHER MATTERS
 
     In 1996, the Company acquired Intelligent Visual Computing Inc. ("IVC"),
Rapid Systems Solutions, Inc. ("Rapid Systems"), BSG and HDS in acquisitions
accounted for as poolings-of-interests. A reconciliation of revenue, pro forma
net income and pro forma net income per common share of the Company, as
originally reported (which includes IVC), with the Company after restating for
the mergers with Rapid Systems, BSG and HDS, including the pro forma provision
for "S" corporation income taxes, is as follows:
 
<TABLE>
<CAPTION>
                                                                  THREE MONTHS ENDED
                                                                    MARCH 31, 1996
                                                                  ------------------
                                                                    (IN THOUSANDS,
                                                                   EXCEPT PER SHARE
                                                                        DATA)
                                                                    (AS RESTATED,
                                                                     SEE NOTE 8)
    <S>                                                           <C>
    Revenue:
      Medaphis, as originally reported..........................       $136,582
      Restatement adjustments...................................         (2,878)
                                                                       --------
      Medaphis, as restated.....................................        133,704
      Rapid Systems.............................................          5,248
      BSG, as restated..........................................         19,539
      HDS.......................................................          3,758
                                                                       --------
      Combined..................................................       $162,249
                                                                       ========
    Pro forma net income (loss):
      Medaphis, as originally reported..........................       $ 13,198
      Restatement adjustments...................................         (6,155)
                                                                       --------
      Medaphis, as restated.....................................          7,043
      Rapid Systems.............................................           (852)
      BSG, as restated..........................................          2,497
      HDS.......................................................            382
      Pro forma provision for Rapid Systems.....................            354
                                                                       --------
      Combined..................................................       $  9,424
                                                                       ========
    Pro forma net income per common share:
      Medaphis, as originally reported..........................       $   0.23
                                                                       ========
      Medaphis, as restated.....................................       $   0.12
                                                                       ========
      Combined..................................................       $   0.12
                                                                       ========
</TABLE>
 
     In February 1996, the Company, through its wholly owned indirect
subsidiary, Imonics GMBH, entered into a joint venture (the "Joint Venture").
The Joint Venture was formed in order to provide customer-service related work
flow applications throughout Europe. Each partner holds a 50% interest in the
Joint Venture. During the quarter ended March 31, 1996, the Joint Venture signed
an agreement with a German telecommunications entity to provide systems
integration and work flow engineering systems and services over a multi-year
contract. Included in revenue in the accompanying Consolidated Statement of
Operations, for the quarter ended March 31, 1996, is approximately $12.5 million
relating to the Company's share of net earnings of the Joint Venture.
 
                                       10
<PAGE>   11
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
NOTE 4 -- RESTRUCTURING AND OTHER CHARGES
 
     Components of restructuring and other charges are as follows:
 
<TABLE>
<CAPTION>
                                                                    MARCH 31,
                                                                       1996
                                                                  --------------
                                                                  (AS RESTATED,
                                                                   SEE NOTE 8)
                                                                  (IN THOUSANDS)
    <S>                                                           <C>
    Restructuring charges.......................................     $ 2,099
    Pooling charges.............................................      (1,793)
                                                                     -------
                                                                     $   306
                                                                     =======
</TABLE>
 
     Restructuring Charges.  During the first quarter of 1996, the Company
incurred approximately $2.1 million of costs which were related to the Company's
reengineering and consolidation project which had not previously been accrued.
 
     Pooling Charges.  In connection with the IVC merger, the Company incurred
estimated transaction fees, costs and expenses of $200,000. In addition,
management revised its estimate of certain transaction fees, costs and expenses
associated with the mergers recorded using the pooling-of-interests method of
accounting consummated in 1995 and reversed estimated charges which had been
reflected in the Company's operating results in the periods the mergers were
consummated.
 
<TABLE>
<CAPTION>
                                                                MARCH 31,
                                                                   1996
                                                              --------------
                                                              (AS RESTATED,
                                                               SEE NOTE 8)
                                                              (IN THOUSANDS)
<S>                                                           <C>
IVC.........................................................     $   200
Automation Atwork Companies.................................        (408)
Healthcare Recoveries, Inc. ("HRI").........................        (765)
Consort Technologies, Inc...................................        (526)
Other.......................................................        (294)
                                                                 -------
                                                                 $(1,793)
                                                                 =======
</TABLE>
 
     A description of the type and amount of exit costs incurred in the quarter
ended March 31, 1997 are as follows:
 
<TABLE>
<CAPTION>
                                                                  RESERVE    INCURRED   RESERVE
                                                                  BALANCE    THROUGH    BALANCE
                                                                  12/31/96   3/31/97    3/31/97
                                                                  --------   --------   -------
                                                                         (IN THOUSANDS)
    <S>                                                           <C>        <C>        <C>
    Lease termination costs.....................................  $ 7,514    $(1,188)   $6,326
    Severance...................................................    2,748       (799)    1,949
    Other.......................................................    1,222       (816)      406
                                                                  -------    -------    ------
                                                                  $11,484    $(2,803)   $8,681
                                                                  =======    =======    ======
</TABLE>
 
NOTE 5 -- INCOME TAXES
 
     In 1996, Medaphis acquired IVC, Rapid Systems and BSG in merger
transactions which were accounted for as poolings-of-interests. Prior to such
mergers, IVC, Rapid Systems and a company acquired by BSG prior to the BSG
merger had elected "S" corporation status for income tax purposes. As a result
of such mergers (or, in the case of the company acquired by BSG, its acquisition
by BSG), such entities terminated their "S"
 
                                       11
<PAGE>   12
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
corporation elections. Pro forma net income and pro forma net income per common
share are presented as if the entities had been "C" corporations during the
three months ended March 31, 1996.
 
NOTE 6 -- LINES OF BUSINESS
 
     Medaphis has five reportable segments: Physician Services, Hospital
Services, HRI, HIT, and the BSG Group. Physician Services is the largest
provider of business management solutions and claims processing to physicians in
the United States. Hospital Services is the largest provider of business
management services to hospitals in the United States. HRI provides subrogation
and related recovery services primarily to healthcare payors. HIT provides
application software and systems integration services to both hospitals and
physicians. The BSG Group provides full-service systems integration, information
technology consulting and tailored software development to more than 100 clients
in a variety of markets, including healthcare.
 
     The accounting policies of the segments are the same as those described in
the summary of significant accounting policies included in the Form 10-K.
Medaphis evaluates each segments' performance based on operating profit or loss.
The Company also accounts for intersegment sales as if the sales were to third
parties.
 
     Information concerning the operations in these reportable segments is as
follows:
 
<TABLE>
<CAPTION>
                                                                          THREE MONTHS ENDED
                                                                              MARCH 31,
                                                                  ----------------------------------
                                                                       1997               1996
                                                                  ---------------    ---------------
                                                                  (IN THOUSANDS)     (IN THOUSANDS)
                                                                   (AS RESTATED,      (AS RESTATED,
                                                                    SEE NOTE 8)        SEE NOTE 8)
    <S>                                                           <C>                <C>
    Revenue:
      Physician Services........................................     $ 71,760           $ 76,247
      Hospital Services.........................................       23,756             22,281
      HRI.......................................................        8,916              6,676
      HIT.......................................................       19,690             16,212
      BSG Group.................................................       23,810             41,263
      Corporate and Eliminations................................         (386)              (430)
                                                                     --------           --------
                                                                     $147,546           $162,249
                                                                     ========           ========
</TABLE>
 
                                       12
<PAGE>   13
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
<TABLE>
<CAPTION>
                                                                          THREE MONTHS ENDED
                                                                              MARCH 31,
                                                                  ----------------------------------
                                                                       1997               1996
                                                                  ---------------    ---------------
                                                                  (IN THOUSANDS)     (IN THOUSANDS)
    <S>                                                           <C>                <C>
    Operating profit (loss)(1):
      Physician Services........................................     $  1,241           $   (268)
      Hospital Services.........................................        2,483              4,674
      HRI.......................................................        2,253              1,388
      HIT.......................................................        2,818              3,597
      BSG Group.................................................          274             14,241
      Corporate and Eliminations................................       (8,442)            (4,921)
                                                                     --------           --------
                                                                     $    627           $ 18,711
                                                                     ========           ========
    Interest expense, net.......................................     $  6,115           $  2,105
                                                                     --------           --------
    Restructuring and other charges:
      Physician Services........................................     $     --           $  1,805
      Hospital Services.........................................           --                 --
      HRI.......................................................           --               (765)
      HIT.......................................................           --               (934)
      BSG Group.................................................           --                200
      Corporate.................................................           --                 --
                                                                     --------           --------
                                                                           --                306
                                                                     --------           --------
    Income (loss) before income taxes...........................     $ (5,488)          $ 16,300
                                                                     ========           ========
    Depreciation and amortization:
      Physician Services........................................     $  8,494           $  7,515
      Hospital Services.........................................        1,278              1,200
      HRI.......................................................          245                195
      HIT.......................................................        1,710              1,486
      BSG Group.................................................        1,045              1,744
      Corporate.................................................          327                333
                                                                     --------           --------
                                                                     $ 13,099           $ 12,473
                                                                     ========           ========
    Capital expenditures:
      Physician Services........................................     $  1,272             12,787
      Hospital Services.........................................          786              1,482
      HRI.......................................................           51                305
      HIT.......................................................          665                966
      BSG Group.................................................          609              3,337
      Corporate.................................................           17                590
                                                                     --------           --------
                                                                     $  3,400           $ 19,467
                                                                     ========           ========
</TABLE>
 
                                       13
<PAGE>   14
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
<TABLE>
<CAPTION>
                                                                              AS OF
                                                                ----------------------------------
                                                                   MARCH 31,        DECEMBER 31,
                                                                     1997               1996
                                                                ---------------    ---------------
                                                                (IN THOUSANDS)     (IN THOUSANDS)
                                                                 (AS RESTATED       (AS RESTATED
                                                                  SEE NOTE 8)        SEE NOTE 8)
  <S>                                                           <C>                <C>
  Identifiable assets:
    Physician Services........................................     $600,765           $610,150
    Hospital Services.........................................      100,288             97,626
    HRI.......................................................       24,947             23,863
    HIT.......................................................       66,450             67,961
    BSG Group.................................................       44,334             51,972
    Corporate.................................................       93,894             85,282
                                                                   --------           --------
                                                                   $930,678           $936,854
                                                                   ========           ========
</TABLE>
 
---------------
 
(1) Excludes restructuring and other charges, litigation settlement and interest
    expense.
 
NOTE 7 -- LONG-TERM DEBT
 
     On February 4, 1997, the Company entered into the Second Amended and
Restated Credit Agreement (the "Second Amended Facility"). This agreement
replaced the Company's previous senior credit facility and increased the
revolving line of credit to $285 million. The Second Amended Facility is
composed of a $275 million revolving line of credit and a $10 million cash
management swing loan line with lenders from a six-bank syndicate. The Second
Amended Facility effectively refinanced the loans outstanding under the previous
senior credit facility and can be used to finance working capital and other
general corporate needs. The Second Amended Facility provides for "base rate"
loans which bear interest equal to prime plus 1% as long as certain financial
covenants are met. The loan commitments under the Second Amended Facility will
reduce to $200 million and $150 million on July 31, 1997 (unless extended by the
lenders until September 30, 1997) and January 31, 1998, respectively. The
Company does not and did not expect to generate sufficient cash flow from
operations to satisfy the required reductions in debt. Management of the Company
has adopted plans to divest HRI and is seeking alternatives for the BSG Group,
which management believes will generate sufficient net proceeds to meet the
reduction in the loan commitments required by the Second Amended Facility. The
Company has retained an investment banking firm to advise it on the divestiture
of HRI as well as to assist in the evaluation of alternatives for the BSG Group.
While management is confident the Company will be able to meet its debt service
obligations, there can be no assurance that the Company will be successful in
its efforts to divest HRI or the BSG Group. If the Company is unable to dispose
of HRI or the BSG Group or through other means generate sufficient net proceeds
to satisfy the required reductions in the loan commitments, the Company's
lenders can cause the borrowings under the Second Amended Facility to become
immediately due and payable. The Second Amended Facility also contains
restrictions on the Company's ability to declare or pay cash dividends on its
common stock.
 
     As part of the consideration paid to the six-bank syndicate for the Second
Amended Facility, the Company issued the lenders warrants with vesting for 1% of
the common stock of the Company on each of January 1, 1998 and April 1, 1998.
The warrants terminate if the Company has no outstanding borrowings on the line
of credit on December 31, 1997. The Company has not allocated any value to these
warrants because management believes the Company will realize sufficient net
proceeds from the divestiture of HRI and the potential alternatives for the BSG
Group or the refinancing of any remaining borrowings under the Second Amended
Facility to enable the Company to repay all borrowings under the Second Amended
Facility by December 31, 1997.
 
                                       14
<PAGE>   15
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
NOTE 8 -- RESTATEMENT OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTERLY
PERIOD ENDED MARCH 31, 1996 AND 1997
 
     As a result of a review initiated by senior management and the Audit
Committee of the Board of Directors (the "Audit Committee") in March 1997 prior
to completion of the audit process for the Company's 1996 fiscal year,
information was developed that certain revenues and expenses may have been
recorded incorrectly between certain quarters during 1996. At the conclusion of
the review, the Company determined that there were certain accounting errors and
irregularities and that its interim financial statements for each fiscal quarter
of 1996 required restatement. These errors and irregularities consisted
primarily of the following: (1) incorrect quarterly recording of revenues and
the related costs and expenses for certain contracts; (2) incorrect quarterly
recording of certain liabilities for employee bonuses and related expenses; (3)
certain costs and expenses of certain acquired companies, which were later
determined not to be properly recordable, were recognized by those companies in
periods prior to their acquisitions, resulting in an overstatement of the
Company's earnings subsequent to those acquisitions; and (4) incorrect
depreciation of certain assets related to the Company's comprehensive
reengineering and consolidation project.
 
     During the third quarter of 1997, in connection with a refinancing effort
of the Company's then credit agreement, management evaluated certain revenue
practices at Health Data Sciences Corporation ("HDS"), a wholly-owned subsidiary
of the Company which was acquired by the Company in a merger transaction in June
1996 that was accounted for as a pooling of interests. These practices related
principally to revenue recognized in fiscal years 1994, 1995 and 1996. As
disclosed by the Company in its Form 10-Q for its fiscal quarter ending
September 30, 1997, management determined that certain revenue of HDS was
improperly recognized and, accordingly, determined to restate its financial
statements for its 1994, 1995 and 1996 fiscal years and the first two fiscal
quarters of its 1997 fiscal year. The effect of such restatements on the
Company's net income (loss) for the years ended December 31, 1994, 1995 and 1996
was ($5.8) million, $(1.1) million and $(7.3) million, respectively. The
cumulative reduction in assets caused by such restatement was $20.5 million.
 
     As a result of the HDS related restatements, Deloitte & Touche, the
predecessor accountant withdrew its audit opinion dated March 31, 1997 in
respect of the Company's 1994, 1995 and 1996 fiscal years. Consequently, the
Company engaged Price Waterhouse to re-audit the Company's 1995 and 1996 fiscal
years and audit the Company's nine-month period ending September 30, 1997.
 
     Subsequent to the restatement related to HDS and in connection with the
reaudit of the Company's fiscal years ended December 31, 1995 and 1996 and the
audit of the Company's nine months ended September 30, 1997 by Price Waterhouse,
the Board of Directors of the Company determined, upon recommendation of the
Audit Committee of the Board, to restate the results of such periods to account
for the December 1995 acquisition of Medical Management Sciences, Inc. ("MMS")
on a purchase accounting basis. The MMS transaction had been accounted for as a
pooling of interests.
 
     The Company has determined that all appropriate adjustments have been made
to its interim financial statements and that its consolidated financial
statements, taken as a whole, present fairly in all material respects the
Company's financial position, results of operations and cash flows for its
fiscal quarter ended March 31, 1996 and 1997 in conformity with generally
accepted accounting principles.
 
                                       15
<PAGE>   16
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
<TABLE>
<CAPTION>
                                                               THREE MONTHS ENDED MARCH 31, 1996
                                                              ------------------------------------
                                                                  AS            AS
                                                              ORIGINALLY    PREVIOUSLY      AS
                                                               REPORTED      RESTATED    RESTATED
                                                              -----------   ----------   ---------
                                                                         (IN THOUSANDS,
                                                                     EXCEPT PER SHARE DATA)
<S>                                                           <C>           <C>          <C>
Revenue.....................................................    $163,627      $162,249    $162,249
Salaries and wages..........................................      90,565        91,730      91,730
Other Operating expenses....................................      39,354        39,335      39,335
Depreciation................................................       4,951         5,940       5,940
Amortization................................................       4,909         5,109       6,533
Income before income taxes..................................      21,593        18,088      16,300
Net income..................................................      12,725        10,659       9,070
Pro forma net income........................................      13,079        11,013       9,424
Pro forma net income per common share.......................    $   0.17      $   0.15    $   0.12
</TABLE>
 
<TABLE>
<CAPTION>
                                                               THREE MONTHS ENDED
                                                                 MARCH 31, 1997
                                                              ---------------------
                                                                  AS
                                                              ORIGINALLY      AS
                                                               REPORTED    RESTATED
                                                              ----------   --------
                                                                 (IN THOUSANDS,
                                                                EXCEPT PER SHARE
                                                                      DATA)
<S>                                                           <C>          <C>
Revenue.....................................................   $147,546    $147,546
Salaries and wages..........................................     93,578      93,578
Other operating expenses....................................     40,242      40,242
Depreciation................................................      6,985       6,985
Amortization................................................      4,690       6,114
Income (loss) before income taxes...........................     (4,064)     (5,488)
Pro forma net income (loss).................................     (1,839)     (3,064)
Pro forma net income per common share.......................   $  (0.03)   $  (0.04)
</TABLE>
 
<TABLE>
<CAPTION>
                                                               AS OF DECEMBER 31,
                                                                      1996
                                                              ---------------------
                                                                  AS
                                                              ORIGINALLY      AS
                                                               REPORTED    RESTATED
                                                              ----------   --------
                                                                 (IN THOUSANDS)
<S>                                                           <C>          <C>
Current Assets..............................................   $269,385    $255,239
Total Assets................................................    815,624     936,854
Current Liabilities.........................................    193,752     198,747
Total Liabilities...........................................    423,334     428,329
Total Stockholders' Equity..................................    392,290     508,525
</TABLE>
 
<TABLE>
<CAPTION>
                                                              AS OF MARCH 31, 1997
                                                              ---------------------
                                                                  AS
                                                              ORIGINALLY      AS
                                                               REPORTED    RESTATED
                                                              ----------   --------
                                                                 (IN THOUSANDS)
<S>                                                           <C>          <C>
Current Assets..............................................   $271,003    $256,857
Total Assets................................................    810,673     930,678
Current Liabilities.........................................    241,454     246,449
Total Liabilities...........................................    416,505     421,500
Total Stockholders' Equity..................................    394,168     509,178
</TABLE>
 
                                       16
<PAGE>   17
 
                     MEDAPHIS CORPORATION AND SUBSIDIARIES
 
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- (CONTINUED)
 
NOTE 9 -- NEW ACCOUNTING PRONOUNCEMENT
 
     In February 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 128, "Earnings per Share" ("SFAS No.
128"). SFAS No. 128 provides for new accounting principles used in the
calculation of earnings per share ("EPS") and shall be effective for financial
statements for both interim and annual periods ending after December 15, 1997.
This new pronouncement would not materially effect the EPS calculation for the
three month periods ended March 31, 1997 and 1996.
 
                                       17
<PAGE>   18
 
ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS
 
     Medaphis Corporation, a corporation organized in 1985 under the laws of the
State of Delaware ("Medaphis" or the "Company"), provides business management
services and information products primarily to healthcare providers. Medaphis'
healthcare services are designed to assist its clients with the business
management functions associated with the delivery of healthcare services,
thereby permitting physicians and hospitals to focus on providing quality
medical services to their patients. Medaphis' healthcare information systems
include patient-centered clinical information management systems and
enterprise-wide patient and employee scheduling systems. These systems are
designed to improve efficiency and quality of care within hospitals and emerging
integrated healthcare delivery systems. Medaphis currently provides business
management systems and services to approximately 20,500 physicians and over
2,600 hospitals in all 50 states, subrogation and recovery services to
healthcare plans covering in excess of 32 million people throughout the United
States and systems integration and services in the United States and abroad.
 
     In February 1997, Medaphis announced the implementation during the 1997
fiscal year of a business plan focused on Medaphis' core business and comprised
of the following five components: (1) exiting non-core businesses, such as the
planned sale of Healthcare Recoveries, Inc. ("HRI") that is discussed below; (2)
achieving improved predictability of results through enhanced management
accountability and controls; (3) reducing costs and increasing efficiencies; (4)
emphasizing customer service; and (5) implementing cross-selling initiatives.
 
     Medaphis' business is impacted by trends in the U.S. healthcare industry.
As healthcare expenditures have grown as a percentage of the U.S. gross national
product, public and private healthcare cost containment measures have applied
pressure to the margins of healthcare providers. Historically, some healthcare
payors have willingly paid the prices established by providers while other
healthcare payors, notably the government and managed care companies, have paid
far less than established prices (in many cases less than the average cost of
providing the services). As a consequence, prices charged to healthcare payors
willing to pay established prices have increased in order to recover the cost of
services purchased by the government and others but not paid by them (i.e.,
"cost shifting"). The increasing complexity in the reimbursement system and
assumption of greater payment responsibility by individuals have caused
healthcare providers to experience increased receivables and bad debt levels and
higher business office costs. Healthcare providers historically have addressed
these pressures on profitability by increasing their prices, by relying on
demographic changes to support increases in the volume and intensity of medical
procedures, and by cost shifting. Notwithstanding providers' responses to
revenue pressures, management believes that the revenue growth rate experienced
by the Company's clients continues to be adversely affected by increased managed
care and other industry factors impacting healthcare providers in the United
States. At the same time, the process of submitting healthcare claims for
reimbursement to third-party payors in accordance with applicable industry and
regulatory standards continues to grow in complexity and to become more costly.
 
     Management believes that these trends have placed pressure on the rate of
the revenue growth and profit margins of the Company's physician accounts
receivable and practice management operations. Due to these revenue and margin
pressures, Medaphis Physicians Services Corporation ("MPSC"), the Company's
largest subsidiary providing accounts receivable and practice management
services to physicians, did not significantly contribute to the Company's
operating profit for 1996 and this trend is not expected to improve until
further progress is made with, among other things, ongoing initiatives designed
to reduce redundant costs, improve efficiencies and enhance operational
effectiveness in MPSC's operations.
 
                                       18
<PAGE>   19
 
RESULTS OF OPERATIONS
 
     The following table shows the percentage of certain items reflected in the
Company's statements of operations to revenue.
 
<TABLE>
<CAPTION>
                                                                     THREE MONTHS ENDED
                                                                         MARCH 31,
                                                              --------------------------------
                                                                   1997              1996
                                                              --------------    --------------
                                                               (AS RESTATED      (AS RESTATED
                                                               SEE NOTE 8)       SEE NOTE 8)
<S>                                                           <C>               <C>
Revenue.....................................................      100.0%            100.0%
Salaries and wages..........................................       63.4              56.5
Other operating expenses....................................       27.3              24.2
Depreciation................................................        4.7               3.7
Amortization................................................        4.1               4.0
Interest expense, net.......................................        4.1               1.3
Restructuring and other charges.............................        0.0               0.2
                                                                  -----             -----
Income (loss) before income taxes...........................       (3.6)             10.1
Income taxes................................................       (1.6)              4.5
                                                                  -----             -----
Net income (loss)...........................................       (2.0)              5.6
Pro forma adjustments.......................................         --               0.2
                                                                  -----             -----
Pro forma net income (loss).................................       (2.0)%             5.8%
                                                                  =====             =====
</TABLE>
 
     Revenue.  Revenue classified by the Company's different operating segments
is as follows:
 
<TABLE>
<CAPTION>
                                                                    THREE MONTHS ENDED
                                                                         MARCH 31,
                                                              -------------------------------
                                                                   1997             1996
                                                              --------------   --------------
                                                                      (IN THOUSANDS)
                                                               (AS RESTATED     (AS RESTATED
                                                               SEE NOTE 8)      SEE NOTE 8)
<S>                                                           <C>              <C>
     Revenue:
       Physician Services...................................     $ 71,760         $ 76,247
       Hospital Services....................................       23,756           22,281
       HRI..................................................        8,916            6,676
       HIT..................................................       19,690           16,212
       BSG Group............................................       23,810           41,263
       Corporate and Eliminations...........................         (386)            (430)
                                                                 --------         --------
                                                                 $147,546         $162,249
                                                                 ========         ========
</TABLE>
 
     As part of the 1997 operating plan, management's primary emphasis is on
improving the services provided to its existing clients and not on growing its
revenue base.
 
     The slight decrease in Physician Services' revenue in the first quarter of
1997 from the same period of 1996 is attributable to the above-mentioned revenue
pressure on the physician accounts receivable and practice management operations
and the emphasis of improving customer service.
 
     The 42.3% decrease in the BSG Group's revenue is primarily a result of the
Company's decision to shut down its wholly-owned operating subsidiary, Imonics
Corporation ("Imonics"). Imonics generated approximately $16.5 million during
the three month period ended March 31, 1996.
 
     HIT's revenue increased 21.5% during the three months ended March 31, 1997
as compared with the same period for the prior year. This increase is primarily
a result of an increase in the number of healthcare information system licenses
sold by Healthcare Data Sciences Corporation.
 
     Salaries and Wages.  Salaries and wages increased to 63.4% of revenue in
the first quarter of 1997 from 56.5% in the first quarter of 1996. The increase
in salaries and wages, as a percentage of revenue, is due to a
 
                                       19
<PAGE>   20
 
slowdown in the growth of the Company's revenue. The Company has not reduced its
employment levels to coincide with the decrease in revenue because the 1997
operating plan has placed a renewed emphasis on client service.
 
     Other Operating Expenses.  Other operating expenses increased to 27.3% of
revenue in the first quarter of 1997 compared to 24.2% in the first quarter of
1996. The increase in other operating expenses as a percentage of revenue for
1997, as compared with 1996, is due to the previously mentioned slowdown in the
growth of the Company's revenue. Other operating expenses are primarily
comprised of postage, facility and equipment rental, telecommunications, travel,
outside consulting and legal services and office supplies.
 
     Depreciation.  Depreciation expense was $7.0 million in the first quarter
of 1997 as compared with $5.9 million in the first quarter of 1996. This
increase reflects the Company's investment in property and equipment to support
its business.
 
     Amortization.  Amortization of intangible assets, which are primarily
associated with the Company's acquisitions and internally developed software,
was $6.1 million in the first quarter of 1997 as compared with $6.5 million in
the first quarter of 1996. The decrease is primarily due to the write-off of
Imonics' purchased goodwill.
 
     Interest.  Net interest expense was $6.1 million in the first quarter of
1997 as compared with $2.1 million in the first quarter of 1996. The increase is
primarily due to increased borrowing under the Company's Second Amended
Facility. Management anticipates that future interest expense will be impacted
by interest rate fluctuations and changes in the amount of borrowings under the
Second Amended and Restated Credit Agreement (the "Second Amended Facility").
 
     Restructuring and Other Charges.  Components of restructuring and other
charges are as follows:
 
<TABLE>
<CAPTION>
                                                                 MARCH 31,
                                                                   1996
                                                              ---------------
                                                              (IN THOUSANDS)
                                                               (AS RESTATED)
                                                                SEE NOTE 8
<S>                                                           <C>
     Restructuring charges..................................      $ 2,099
     Pooling charges........................................       (1,793)
                                                                  -------
                                                                  $   306
                                                                  =======
</TABLE>
 
     Restructuring Charges.  During the first quarter of 1996, the Company
incurred approximately $2.1 million of costs which were related to the Company's
reengineering and consolidation project which had not previously been accrued.
 
     Pooling Charges.  In connection with the Intelligent Visual Computing, Inc.
("IVC") merger, the Company incurred estimated transaction fees, costs and
expenses of $200,000. In addition, management revised its estimate of certain
transaction fees, costs and expenses associated with the mergers recorded using
the pooling-of-interests method of accounting consummated in 1995 and reversed
estimated charges which had been reflected in the Company's operating results in
the periods the mergers were consummated.
 
<TABLE>
<CAPTION>
                                                                   1996
                                                              --------------
                                                              (IN THOUSANDS)
                                                              (AS RESTATED)
                                                                SEE NOTE 8
<S>                                                           <C>
IVC.........................................................     $   200
Automation Atwork Companies.................................        (408)
HRI.........................................................        (765)
Consort Technologies, Inc...................................        (526)
Other.......................................................        (294)
                                                                 -------
                                                                 $(1,793)
                                                                 =======
</TABLE>
 
                                       20
<PAGE>   21
 
     Income (Loss) Before Income Taxes.  The Company's loss before income taxes
was (3.6)% of revenue in the first quarter of 1997 as compared with income of
10.1% of revenue in the first quarter of 1996. The decrease is primarily the
result of the aforementioned revenue decreases.
 
     Income Taxes.  Effective income tax rates for the periods presented vary
from statutory rates primarily as a result of nondeductible goodwill associated
with merger transactions consummated by the Company in previous years. Pro forma
adjustments for income taxes have been provided for companies accounted for
under the pooling-of-interest method of accounting which elected to be treated
as "S" corporations under the Internal Revenue Code of 1986, as amended, prior
to merging with the Company.
 
LIQUIDITY AND CAPITAL RESOURCES
 
     The Company had working capital of $10.4 million at March 31, 1997,
including $10.2 million of cash.
 
     The Company's operating activities generated cash of $5.9 million during
the three months ended March 31, 1997 as compared with the use of cash of $4.2
million during the three months ended March 31, 1996. The increase in the
Company's operating cash flows resulted primarily from the collection of
outstanding receivables and management's cash control initiatives.
 
     On February 4, 1997, the Company entered into the Second Amended Facility
which replaced the Company's previous revolving credit agreement and increased
the revolving line of credit from $250 million to $285 million. At March 31,
1997, the Company had $244 million in borrowings outstanding under the Second
Amended Facility which bore interest at 9.5%. The Second Amended Facility
expires on June 30, 1998 and may be extended or otherwise amended pursuant to
the agreement. Borrowings under the Second Amended Facility are secured by
substantially all of the Company's assets and are guaranteed by substantially
all of the Company's subsidiaries. The Second Amended Facility effectively
refinanced the loans outstanding under the Company's previous senior credit
facility and can be used to finance working capital and other general corporate
needs with restrictions on new acquisitions, certain litigation settlement
payments and capital expenditures for the fiscal quarter ending March 31, 1996.
The Second Amended Facility provides for "base rate" loans which bear interest
equal to prime plus 1% as long as certain financial covenants are met. The loan
commitments under the Second Amended Facility will reduce to $200 million and
$150 million on July 31, 1996 (unless extended by the lenders to September 30,
1997) and January 31, 1998, respectively. In late 1996 and in 1997, the Company
has taken actions to reduce capital expenditures and to monitor uses of cash.
The Company believes that it will be able to fund its operating cash
requirements through operating cash flows and borrowings under the Second
Amended Facility through July 31, 1997, when the Company will be required to
reduce the outstanding amount of borrowings under the Second Amended Facility to
a maximum of $200 million. In developing its 1997 business plan, the Company did
not expect to generate sufficient cash flow from operations to meet the required
debt reduction and, therefore, management has adopted plans to divest HRI and is
seeking alternatives for the BSG Group, which it believes will generate
sufficient net proceeds to meet the July 31, 1997 reduction in the loan
commitments required by the Second Amended Facility. The Company has retained
investment banking counsel to advise it on the divestiture of HRI as well as to
assist in the evaluation of alternatives for the BSG Group. On March 14, 1997,
the Company filed a registration statement with the Commission relating to the
planned initial public offering of 100% of the common stock of HRI. This initial
public offering is subject to review by the Commission and the marketability of
HRI. There can be no assurance that the Company will be successful in its
efforts to sell HRI and/or the BSG Group. If the Company is unable to generate
sufficient net proceeds through the sale of HRI and/or the BSG Group or obtain
alternative debt financing by July 31, 1997 (unless extended by the lenders
until September 30, 1997), the Company's lenders can cause the borrowing under
the Second Amended Facility to become immediately due and payable.
 
     As part of the consideration paid to the six-bank syndicate for the Second
Amended Facility, the Company issued the lenders warrants with vesting
arrangements for 1% of the Common Stock of the Company on each of January 1,
1998 and April 1, 1998. These warrants terminate if the Company has no
outstanding borrowings on the line of credit on December 31, 1997. The Company
has not allocated any value to these warrants because management believes the
Company will generate sufficient cash flows from asset
 
                                       21
<PAGE>   22
 
sales or the refinancing of any remaining borrowings under the Second Amended
Facility to repay all the borrowings under the Second Amended Facility by
December 31, 1997.
 
OTHER MATTERS
 
     As a result of a review initiated by senior management and the Audit
Committee of the Board of Directors (the "Audit Committee") in March 1997 prior
to completion of the audit process for the Company's 1996 fiscal year,
information was developed that certain revenues and expenses may have been
recorded incorrectly between certain quarters during 1996. At the conclusion of
the review, the Company determined that there were certain accounting errors and
irregularities and that its interim financial statements for each fiscal quarter
of 1996 required restatement. These errors and irregularities consisted
primarily of the following: (1) incorrect quarterly recording of revenues and
the related costs and expenses for certain contracts; (2) incorrect quarterly
recording of certain liabilities for employee bonuses and related expenses; (3)
certain costs and expenses of certain acquired companies, which were later
determined not to be properly recordable, were recognized by those companies in
periods prior to their acquisitions, resulting in an overstatement of the
Company's earnings subsequent to those acquisitions; and (4) incorrect
depreciation of certain assets related to the Company's comprehensive
reengineering and consolidation project.
 
     During the third quarter of 1997, in connection with a refinancing effort
of the Company's then credit agreement, management evaluated certain revenue
practices at Health Data Sciences Corporation ("HDS"), a wholly-owned subsidiary
of the Company which was acquired by the Company in a merger transaction in June
1996 that was accounted for as a pooling of interests. These practices related
principally to revenue recognized in fiscal years 1994, 1995 and 1996. As
disclosed by the Company in its Form 10-Q for its fiscal quarter ending
September 30, 1997, management determined that certain revenue of HDS was
improperly recognized and, accordingly, determined to restate its financial
statements for its 1994, 1995 and 1996 fiscal years and the first two fiscal
quarters of its 1997 fiscal year. The effect of such restatements on the
Company's net income (loss) for the years ended December 31, 1994, 1995 and 1996
was ($5.8) million, $(1.1) million and $(7.3) million, respectively. The
cumulative reduction in assets caused by such restatement was $20.5 million.
 
     As a result of the HDS related restatements, Deloitte & Touche, the
predecessor accountant withdrew its audit opinion dated March 31, 1997 in
respect of the Company's 1994, 1995 and 1996 fiscal years. Consequently, the
Company engaged Price Waterhouse to re-audit the Company's 1995 and 1996 fiscal
years and audit the Company's nine-month period ending September 30, 1997.
 
     Subsequent to the restatement related to HDS and in connection with the
reaudit of the Company's fiscal years ended December 31, 1995 and 1996 and the
audit of the Company's nine months ended September 30, 1997 by Price Waterhouse,
the Board of Directors of the Company determined, upon recommendation of the
Audit Committee of the Board, to restate the results of such periods to account
for the December 1995 acquisition of Medical Management Sciences, Inc. ("MMS")
on a purchase accounting basis. The MMS transaction had been accounted for as a
pooling of interests.
 
     The Company has determined that all appropriate adjustments have been made
to its interim financial statements and that its consolidated financial
statements, taken as a whole, present fairly in all material respects the
Company's financial position, results of operations and cash flows for its
fiscal quarter ended March 31, 1996 and 1997 in conformity with generally
accepted accounting principles.
 
                                       22
<PAGE>   23
 
<TABLE>
<CAPTION>
                                                                         THREE MONTHS ENDED
                                                                           MARCH 31, 1996
                                                             -------------------------------------------
                                                             AS ORIGINALLY   AS PREVIOUSLY
                                                               REPORTED        RESTATED      AS RESTATED
                                                             -------------   -------------   -----------
                                                                           (IN THOUSANDS,
                                                                       EXCEPT PER SHARE DATA)
<S>                                                          <C>             <C>             <C>
Revenue....................................................    $163,627        $162,249       $162,249
Salaries and wages.........................................      90,565          91,730         91,730
Other Operating expenses...................................      39,354          39,335         39,335
Depreciation...............................................       4,951           5,940          5,940
Amortization...............................................       4,909           5,109          6,533
Income before income taxes.................................      21,593          18,088         16,300
Net income.................................................      12,725          10,659          9,070
Pro forma net income.......................................      13,079          11,013          9,424
Pro forma net income per common share......................    $   0.17        $   0.15       $   0.12
</TABLE>
 
<TABLE>
<CAPTION>
                                                               THREE MONTHS ENDED
                                                                 MARCH 31, 1997
                                                              ---------------------
                                                                  AS
                                                              ORIGINALLY      AS
                                                               REPORTED    RESTATED
                                                              ----------   --------
                                                                 (IN THOUSANDS,
                                                                EXCEPT PER SHARE
                                                                      DATA)
<S>                                                           <C>          <C>
Revenue.....................................................   $147,546    $147,546
Salaries and wages..........................................     93,578      93,578
Other operating expenses....................................     40,242      40,242
Depreciation................................................      6,985       6,985
Amortization................................................      4,690       6,114
Income (loss) before income taxes...........................     (4,064)     (5,488)
Pro Forma net income (loss).................................     (1,839)     (3,064)
Pro Forma net income per common share.......................   $  (0.03)   $  (0.04)
</TABLE>
 
<TABLE>
<CAPTION>
                                                               AS OF DECEMBER 31,
                                                                      1996
                                                              ---------------------
                                                                  AS
                                                              ORIGINALLY      AS
                                                               REPORTED    RESTATED
                                                              ----------   --------
                                                                 (IN THOUSANDS)
<S>                                                           <C>          <C>
Current Assets..............................................   $269,385    $255,239
Total Assets................................................    815,624     936,854
Current Liabilities.........................................    193,752     198,747
Total Liabilities...........................................    423,334     428,329
Total Stockholders' Equity..................................    392,290     508,525
</TABLE>
 
<TABLE>
<CAPTION>
                                                              AS OF MARCH 31, 1997
                                                              ---------------------
                                                                  AS
                                                              ORIGINALLY      AS
                                                               REPORTED    RESTATED
                                                              ----------   --------
                                                                 (IN THOUSANDS)
<S>                                                           <C>          <C>
Current Assets..............................................   $271,003    $256,857
Total Assets................................................    810,673     930,678
Current Liabilities.........................................    241,454     246,449
Total Liabilities...........................................    416,505     421,500
Total Stockholders' Equity..................................    394,168     509,178
</TABLE>
 
                                       23
<PAGE>   24
 
PART II:  OTHER INFORMATION
 
ITEM 1.  LEGAL PROCEEDINGS
 
     The United States Attorney's Office for the Central District of California
is conducting an investigation (the "Federal Investigation") of Medaphis'
billing and collection practices in its offices located in Calabasas and
Cypress, California (the "Designated Offices"). Medaphis first became aware of
the Federal Investigation when it received search warrants and grand jury
subpoenas on June 13, 1995. Although the precise scope of the Federal
Investigation is not known to the Company at this time, Medaphis believes that
the U.S. Attorney's Office is investigating allegations of billing fraud and
that the inquiry is focused upon Medaphis' billing and collection practices in
the Designated Offices. Numerous federal and state civil and criminal laws
govern medical billing and collection activities. In general, these laws provide
for various fines, penalties, multiple damages, assessments and sanctions for
violations, including possible exclusion from Medicare, Medicaid and certain
other federal and state healthcare programs. Although the Designated Offices
represent less than 2% of Medaphis' annual revenue, there can be no assurance
that the Federal Investigation will be resolved promptly, that additional
subpoenas or search warrants will not be received by Medaphis or that the
Federal Investigation will not have a material adverse effect upon the Company.
The Company recorded charges of $12 million in the third quarter of 1995 and $2
million in the fourth quarter of 1996, solely for the administrative fees, costs
and expenses it anticipates incurring in connection with the Federal
Investigation and the putative class action lawsuits described below which were
filed following the Company's announcement of the Federal Investigation. The
charges are intended to cover only the anticipated expenses of the Federal
Investigation and the related lawsuits and do not include any provision for
fines, penalties, damages, assessments, judgments or sanctions that may arise
out of such matters.
 
     Following the announcement of the Federal Investigation, Medaphis, various
of its current and former officers and directors and the lead underwriters
associated with Medaphis' public offering of common stock in April 1995 were
named as defendants in putative shareholder class action lawsuits filed in the
United States District Court for the Northern District of Georgia. In general,
these lawsuits allege violations of the federal securities laws in connection
with Medaphis' public statements and filings under the federal securities acts,
including the registration statement filed in connection with Medaphis' public
offering of common stock in April 1995. On October 13, 1995, the named
plaintiffs in these lawsuits filed a consolidated class action complaint (the
"Consolidated Complaint"). On January 3, 1996, the court denied defendants'
motion to dismiss the Consolidated Complaint. On April 11, 1996, certain of the
named plaintiffs to the Consolidated Complaint voluntarily dismissed with
prejudice all of their claims. As a result of these dismissals, the Consolidated
Complaint no longer contains any claims based on the Securities Act of 1933, as
amended, and the Company's underwriters and outside directors are no longer
named as defendants. On June 26, 1996, the court denied the plaintiffs' motion
to certify a plaintiffs' class. The plaintiffs and the defendants have reached
an agreement in principle to settle this action on a class-wide basis for $4.75
million, subject to court approval and other customary conditions (the "1995
Class Action Settlement"). The 1995 Class Action Settlement would also include
the related putative class action lawsuit currently pending in the Superior
Court of Cobb County, Georgia, described more fully below. The Company expects
to receive approximately $3.7 million from insurance to fund a portion of the
1995 Class Action Settlement and accrued approximately $1.2 million in the
quarter ending December 31, 1996 to fund the anticipated balance of the 1995
Class Action Settlement and to pay certain fees incident thereto.
 
     On November 5, 1996, Medaphis, Randolph G. Brown, Michael R. Cote and James
S. Douglass were named as defendants in a putative shareholder class action
lawsuit filed in Superior Court of Cobb County, State of Georgia. This lawsuit
alleges violations of Georgia securities laws based on the same public
statements and filings generally described above. The lawsuit is brought on
behalf of a putative class of purchasers of Medaphis common stock during the
period from March 29, 1995 through June 15, 1995. The plaintiffs seek
compensatory damages and costs. As noted above, it is currently contemplated
that this action will be settled as part of the 1995 Class Action Settlement.
 
     The Company and its clients from time to time have received, and the
Company anticipates that they will receive in the future, official inquiries
(including subpoenas, search warrants, as well as informal requests)
 
                                       24
<PAGE>   25
 
concerning particular billing and collection practices related to certain
subsidiaries of the Company and its many clients. In March 1997, the Company was
informed by the Civil Division of the Department of Justice that it is
investigating allegations concerning the Company's Gottlieb's Financial
Services, Inc. ("GFS") subsidiary. The Company has received a request from the
Department of Justice for records, and may receive additional requests. The
Company intends to cooperate in producing records. There can be no assurance
that this matter will be resolved promptly or that the investigation will not
have a material adverse effect upon Medaphis.
 
     Following the Company's August 14, 1996 announcement regarding earnings
expectations and certain charges, Medaphis and certain of its current and former
officers, one of whom was also a director, were named as defendants in nineteen
putative shareholder class action lawsuits filed in the United States District
Court for the Northern District of Georgia. On November 22, 1996, the plaintiffs
in these lawsuits filed a Consolidated Amended Class Action Complaint (the "1996
Consolidated Complaint"). In general, the 1996 Consolidated Complaint alleges
violations of the federal securities laws in connection with Medaphis' filings
under the federal securities acts and public disclosures. The 1996 Consolidated
Complaint is brought on behalf of a class of all persons who purchased or
otherwise acquired Medaphis common stock between January 6, 1996 and October 21,
1996. The 1996 Consolidated Complaint also asserts claims on behalf of a
sub-class of all persons who acquired Medaphis common stock pursuant to the
merger between Medaphis and Health Data Sciences Corporation ("HDS"). On
December 30, 1996, the defendants filed a motion to dismiss most of the 1996
Consolidated Complaint. On February 3, 1997, the plaintiffs filed a Consolidated
Second Amended Complaint. On February 14, 1997, the defendants moved to dismiss
the Consolidated Second Amended Complaint in its entirety.
 
     On November 1, 1996, Thomas W. Brown, Administrator, Thomas W. Brown Profit
Sharing Plan filed a shareholder derivative lawsuit in the United States
District Court for the Northern District of Georgia alleging that certain of
Medaphis' current and former directors breached their fiduciary duties, were
grossly negligent, and breached various contractual obligations to Medaphis by
allegedly failing to implement and maintain an adequate system of internal
accounting controls, allowing Medaphis to commit securities law violations and
damaging Medaphis' reputation. The plaintiff seeks compensatory damages and
costs. On January 28, 1997, Medaphis and certain individual defendants filed a
motion to dismiss the complaint. On February 11, 1997, the plaintiff filed an
amended complaint adding as defendants additional current and former directors
and officers of Medaphis. On April 23, 1997, Medaphis and certain of the
defendants filed a motion to dismiss the amended complaint.
 
     On November 7, 1996, Health Systems International, Inc. filed suit in the
Superior Court for the State of California, County of Los Angeles against
Medaphis, Randolph G. Brown and "Does 1-50," who are alleged to be unnamed
Medaphis directors, officers and employees. Generally, this lawsuit alleges that
the defendants violated federal and California securities laws and common law
by, among other things more fully described in the complaint, making material
misstatements and omissions in public and private disclosures in connection with
the acquisition of HDS. Plaintiff seeks rescissory, compensatory and punitive
damages, rescission, injunctive relief and costs. On January 10, 1997, the
defendants filed a demurrer to the complaint. The demurrer was denied on
February 5, 1997. On March 18, 1997, the court denied the plaintiff's motion for
a preliminary injunction. As a result of the Company's restatement of its fiscal
1995 financial statements, the Company may not be able to sustain a defense to
strict liability on certain claims under the 1933 Act, but the Company believes
that it has substantial defenses to the alleged damages relating to the 1933 Act
claims.
 
     A putative class action complaint was filed by Ernest Hecht and Stephen D.
Strandberg against Steven G. Papermaster, Robert E. Pickering, Jr., David S.
Lundeen, Norman Smith, Raymond J. Noorda, Gregory A. Grosh, Medaphis and
Randolph G. Brown on November 12, 1996 in the Superior Court, Law Division,
Essex County, State of New Jersey. The alleged class consists of persons and
entities whose options to purchase BSG Corporation ("BSG") common stock were
converted to Medaphis stock options in connection with Medaphis' acquisition of
BSG. The plaintiffs allege failure to perform diligence, breaches of fiduciary
duties of candor, loyalty and fair dealing and negligence against the BSG
defendants (Papermaster, Pickering, Lundeen, Smith, Noorda and Grosh) and fraud
and deceit against the Medaphis defendants (Medaphis and
 
                                       25
<PAGE>   26
 
Brown). On April 18, 1997, the Medaphis defendants and BSG defendants filed
motions to dismiss the complaint.
 
     On February 28, 1997, Steven G. Papermaster, Raymond J. Noorda and two
entities they control made a demand for indemnification under an indemnification
agreement executed by Medaphis in connection with its acquisition of BSG in May
1996. On the date of the demand, Mr. Papermaster was an executive officer and a
director of Medaphis. Mr. Papermaster resigned such positions on March 21, 1997,
although he remains an executive officer of BSG. The indemnification demand
claims damages of $35 million (the maximum damages payable by Medaphis under the
indemnification agreement) for the alleged breach by the Company of its
representations and warranties made in the merger agreement between Medaphis and
BSG.
 
     On April 21, 1997, James F. Thacker, Alyson T. Stinson, Carol T. Shumaker,
Lori T. Caudill, William J. Dezonia, the James F. Thacker Retained Annuity
Trust, and the Paulanne H. Thacker Retained Annuity Trust filed a complaint
against the Company and Randolph G. Brown in the United States District Court
for the Southern District of New York arising out of Medaphis' acquisition of
Medical Management Sciences, Inc. ("MMS") in December of 1995. The complaint is
brought on behalf of all former shareholders of MMS who exchanged their MMS
holdings for unregistered shares of Medaphis common stock. In general, the
complaint alleges both common law fraud and violations of the federal securities
laws in connection with the merger. In addition, the complaint alleges breaches
of contract relating to the merger agreement and a registration rights
agreement, as well as tortious interference with economic advantage. The
plaintiffs seek rescission of the merger agreement and the return of all MMS
shares, as well as damages in excess of $100 million. Additionally, plaintiffs
seek to void various noncompete covenants and contract provisions between
Medaphis and plaintiffs.
 
     The Company also has received other written demands from various
stockholders, including stockholders of recently acquired companies.
 
     On January 8, 1997, the Securities and Exchange Commission (the
"Commission") has notified the Company that it is conducting a non-public
investigation into, among other things, certain trading and other issues related
to Medaphis' August 14, 1996 and October 22, 1996 announcements of the Company's
loss for the quarter ending September 30, 1996 and its restated consolidated
financial statements for the three months and year ended December 31, 1995 and
its restated unaudited balance sheets as of March 31, 1996 and June 30, 1996.
The Company intends to cooperate fully with the Commission in its investigation.
 
     Although the Company believes that it has meritorious defenses to the
claims of liability or for damages in the actions against, and written demands
placed upon the Company, there can be no assurance that additional lawsuits will
not be filed against the Company, that the lawsuits, the written demands and the
pending governmental investigations will not have a disruptive effect upon the
operations of the business, that the written demands, the defense of the
lawsuits and the pending investigations will not consume the time and attention
of the senior management of the Company or that the resolution of the lawsuits,
the written demands and the pending governmental investigations will not have a
material adverse effect upon the Company.
 
ITEM 5.  OTHER INFORMATION
 
     On April 25, 1997, the Compensation Committee of the Board of Directors of
the Company approved an adjustment of the exercise price for certain outstanding
employee stock options which have an exercise price of $5.50 and above. No
adjustments were made to any options held by directors or former employees of
the Company. The revised exercise price of $5.375 was established by reference
to the closing price of the Company's common stock on April 25, 1997. In
approving the adjustment, the Compensation Committee relied upon the views of
its outside advisors with respect to the legal, accounting and compensation
issues associated with the action and took into consideration, among other
things, the following factors: (i) the Company had historically paid salaries
which were at or below market levels and had made up for lower salaries through
stock option grants to employees; (ii) the Company historically had used stock
options as its principal long-term incentive program; (iii) the highly skilled
employees of the Company possessed marketable skills; and (iv) senior management
of the Company believed that there was potential for increased attrition among
its key employees and that adjustment of the exercise price of the outstanding
options would significantly help to mitigate such risk.
 
                                       26
<PAGE>   27
 
ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K
 
(A) EXHIBITS
 
<TABLE>
<CAPTION>
EXHIBIT
NUMBER                           DESCRIPTION OF EXHIBITS
-------                          -----------------------
<C>       <C>  <S>
 3.1       --  Amended and Restated Certificate of Incorporation of
               Registrant (incorporated by reference to Exhibit 3.1 of
               Registrant's Registration Statement on Form S-1, File No.
               33-42216)
 3.2       --  Certificate of Amendment of Certificate of Incorporation of
               Registrant (incorporated by reference to Exhibit 3 of
               Registrant's Quarterly Report on Form 10-Q for the Quarterly
               Period Ended March 31, 1993)
 3.3       --  Certificate of Amendment of Certificate of Incorporation of
               Registrant (incorporated by reference to Exhibit 3.3 to the
               Registrant's Registration Statement on Form 8-A/A, filed on
               May 22, 1996)
 3.4       --  Certificate of Amendment of Amended and Restated Certificate
               of Incorporation of Registrant (incorporated by reference to
               Exhibit 4.4 to the Registration Statement on Form S-8, File
               No. 333-03213)
 3.5       --  Amended and Restated By-Laws of Registrant (incorporated by
               reference to Exhibit 3.2 of Registrant's 1992 Form 10-K,
               File No. 000-19480)
 4.1       --  Form of Warrant issued to one or more lenders pursuant to
               Registrant's Second Amended and Restated Credit Agreement,
               dated as of February 4, 1997 (incorporated by reference to
               Exhibit 4.1 to Current Report on Form 8-K filed on February
               18, 1997)
10.1       --  Sixth Amendment to Medaphis Corporation Non-Qualified Stock
               Option Plan for Employees of Acquired Companies
               (incorporated by reference to Exhibit 10.21 of the Annual
               Report on Form 10-K for the year ended December 31, 1996,
               File No. 000-19480)
10.2       --  First Amendment to Medaphis Corporation Non-Qualified Stock
               Option Plan for Non-Executive Employees (incorporated by
               reference to Exhibit 10.24 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
10.3       --  Employment Agreement by and between Registrant and Daniel S.
               Connors, Jr., dated February 25, 1997 (incorporated by
               reference to Exhibit 10.50 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
10.4       --  Employment Agreement by and between Registrant and Carl
               James Schaper, dated February 25, 1997 (incorporated by
               reference to Exhibit 10.51 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
10.5       --  Employment Agreement by and between Registrant and Jerome H.
               Baglien, dated January 3, 1997 (incorporated by reference to
               Exhibit 10.52 of the Annual Report on Form 10-K for the year
               ended December 31, 1996, File No. 000-19480)
10.6       --  Second Amended and Restated Credit Agreement, dated as of
               February 4, 1997, among the Registrant, the lenders listed
               therein and the Agent (incorporated by reference to Exhibit
               99.2 to Current Report on Form 8-K filed on February 18,
               1997)
10.7       --  Form of Second Amendment to the Amended and Restated
               Medaphis Employees' Retirement Savings Plan (incorporated by
               reference to Exhibit 10.31 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
11         --  Statement regarding Computation of Earnings Per Share
27         --  Financial Data Schedule (for SEC use only)
99.1       --  Safe Harbor Compliance Statement for Forward-Looking
               Statements
</TABLE>
 
                                       27
<PAGE>   28
 
(B) REPORTS ON FORM 8-K
 
     The following reports on Form 8-K have been filed by the Company during the
quarter ended March 31, 1997:
 
<TABLE>
<CAPTION>
                                        FINANCIAL
                                        STATEMENTS
ITEM REPORTED                             FILED       DATE OF REPORT        FILE DATE
-------------                           ----------   -----------------  -----------------
<S>                                     <C>          <C>                <C>
7th Modification of bank agreement....     No        December 31, 1996   January 3, 1997
1996 Year end press release, second
  amended and restated credit
  agreement...........................   Yes(1)      December 31, 1996  February 18, 1997
</TABLE>
 
---------------
 
(1) Consolidated statement of operations for the three months and year ended
    December 31, 1996, condensed consolidated balance sheets as of December 31,
    1996 and 1995 and supplemented consolidated segment data for the quarterly
    periods ended March 31, June 30, September 30 and December 31, 1996 and
    1995.
 
                                       28
<PAGE>   29
 
                                   SIGNATURES
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
 
                                          MEDAPHIS CORPORATION
 
                                          By:      /s/ ALLEN W. RITCHIE
                                             -----------------------------------
                                                         Allen W. Ritchie
                                                         Senior Vice President
                                                         and Chief Financial 
                                                         Officer
                                                                                
 
Date: February 2, 1998
 
                                          By:     /s/ MARK P. COLONNESE
                                             -----------------------------------
                                                         Mark P. Colonnese
                                                         Vice President and
                                                         Corporate Controller
                                                         (Principal Accounting
                                                         Officer)
 
                                       29
<PAGE>   30
 
                               INDEX TO EXHIBITS
 
<TABLE>
<CAPTION>
                                                                             SEQUENTIALLY
EXHIBIT                                                                        NUMBERED
NUMBER                           DESCRIPTION OF EXHIBITS                         PAGE
-------                          -----------------------                     ------------
<C>       <C>  <S>                                                           <C>
 3.1       --  Amended and Restated Certificate of Incorporation of
               Registrant (incorporated by reference to Exhibit 3.1 of
               Registrant's Registration Statement on Form S-1, File No.
               33-42216)
 3.2       --  Certificate of Amendment of Certificate of Incorporation of
               Registrant (incorporated by reference to Exhibit 3 of
               Registrant's Quarterly Report on Form 10-Q for the Quarterly
               Period Ended March 31, 1993)
 3.3       --  Certificate of Amendment of Certificate of Incorporation of
               Registrant (incorporated by reference to Exhibit 3.3 to the
               Registrant's Registration Statement on Form 8-A/A, filed on
               May 22, 1996)
 3.4       --  Certificate of Amendment of Amended and Restated Certificate
               of Incorporation of Registrant (incorporated by reference to
               Exhibit 4.4 to the Registration Statement on Form S-8, File
               No. 333-03213)
 3.5       --  Amended and Restated By-Laws of Registrant (incorporated by
               reference to Exhibit 3.2 of Registrant's 1992 Form 10-K,
               File No. 000-19480)
 4.1       --  Form of Warrant issued to one or more lenders pursuant to
               Registrant's Second Amended and Restated Credit Agreement,
               dated as of February 4, 1997 (incorporated by reference to
               Exhibit 4.1 to Current Report on Form 8-K filed on February
               18, 1997)
10.1       --  Sixth Amendment to Medaphis Corporation Non-Qualified Stock
               Option Plan for Employees of Acquired Companies
               (incorporated by reference to Exhibit 10.21 of the Annual
               Report on Form 10-K for the year ended December 31, 1996,
               File No. 000-19480)
10.2       --  First Amendment to Medaphis Corporation Non-Qualified Stock
               Option Plan for Non-Executive Employees (incorporated by
               reference to Exhibit 10.24 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
10.3       --  Employment Agreement by and between Registrant and Daniel S.
               Connors, Jr., dated February 25, 1997 (incorporated by
               reference to Exhibit 10.50 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
10.4       --  Employment Agreement by and between Registrant and Carl
               James Schaper, dated February 25, 1997 (incorporated by
               reference to Exhibit 10.51 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
10.5       --  Employment Agreement by and between Registrant and Jerome H.
               Baglien, dated January 3, 1997 (incorporated by reference to
               Exhibit 10.52 of the Annual Report on Form 10-K for the year
               ended December 31, 1996, File No. 000-19480)
10.6       --  Second Amended and Restated Credit Agreement, dated as of
               February 4, 1997, among the Registrant, the lenders listed
               therein and the Agent (incorporated by reference to Exhibit
               99.2 to Current Report on Form 8-K filed on February 18,
               1997)
10.7       --  Form of Second Amendment to the Amended and Restated
               Medaphis Employees' Retirement Savings Plan (incorporated by
               reference to Exhibit 10.31 of the Annual Report on Form 10-K
               for the year ended December 31, 1996, File No. 000-19480)
</TABLE>
 
                                       30
<PAGE>   31
<TABLE>
<CAPTION>
                                                                             SEQUENTIALLY
EXHIBIT                                                                        NUMBERED
NUMBER                           DESCRIPTION OF EXHIBITS                         PAGE
-------                          -----------------------                     ------------
<C>       <C>  <S>                                                           <C>
11         --  Statement regarding Computation of Earnings Per Share
27         --  Financial Data Schedule (for SEC use only)
99.1       --  Safe Harbor Compliance Statement for Forward-Looking
               Statements
</TABLE>
 
                                       31